| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |